Association of helicobacter pylori infection with severity of coronary heart disease

ARYA Atherosclerosis

Volumn 7, Issue 4, 2012, Pages 138-141

  Rogha, Mehran ^a   Dadkhah, Davood ^a   Pourmoghaddas, Zahra ^a   Shirneshan, Keivan ^b   Nikvarz, Marjan ^a   Pourmoghaddas, Masoud ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Shariati Hospital of Isfahan   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

CagA; Coronary Heart Disease; Helicobacter Pylori; Severity

Indexed keywords

BACTERIUM ANTIBODY; C REACTIVE PROTEIN; CAGA PROTEIN; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 6;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BLOOD SAMPLING; CARDIOVASCULAR RISK; DIABETES MELLITUS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSLIPIDEMIA; FEMALE; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY;

EID: 84861853242     PISSN: 17353955     EISSN: 22516638     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Onat A, Sari I, Hergenc G, Yazici M, Uyarel H, Can G, et al. Predictors of abdominal obesity and high susceptibility of cardiometabolic risk to its increments among Turkish women: a prospective populationbased study. Metabolism 2007; 56(3): 348-56.
2. Cavender MA, Alexander KP, Broderick S, Shaw LK, McCants CB, Kempf J, et al. Long-term morbidity and mortality among medically managed patients with angina and multivessel coronary artery disease. Am Heart J 2009; 158(6): 933-40.
3. Chen CY, Hwu CM, Lin MW, Tsai CH, Yeh HI. High triglyceride level is associated with severe coronary artery disease in hypertensive subjects. Scand Cardiovasc J 2008; 42(2): 146-52.
4. Ehtisham A, Chimowitz MI, Furlan AJ, Lafranchise EF. Systemic risk factors associated with progression of atherosclerosis from the coronary to the carotid arteries. J Stroke Cerebrovasc Dis 2005; 14(4): 182-5.
5. Lobo RA. Inflammation, coronary artery disease, and hormones. Menopause 2008; 15(6): 1036-8.
6. Rozankovic PB, Huzjan AL, Cupic H, Bencic IJ, Basic S, Demarin V. Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease. J Neurol 2011; 258(5): 753-61.
7. Blum A, Peleg A, Weinberg M. Anticytomegalovirus (CMV) IgG antibody titer in patients with risk factors to atherosclerosis. Clin Exp Med 2003; 3(3): 157-60.
8. Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006; 113(7): 929-37.
9. Fagoonee S, De AC, Elia C, Silvano S, Oliaro E, Rizzetto M, et al. Potential link between Helicobacter pylori and ischemic heart disease: does the bacterium elicit thrombosis? Minerva Med 2010; 101(2): 121-5.
10. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004; 104(4): 161-4.
11. Jin SW, Her SH, Lee JM, Yoon HJ, Moon SJ, Kim PJ, et al. The association between current Helicobacter pylori infection and coronary artery disease. Korean J Intern Med 2007; 22(3): 152-6.
12. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study. BMJ 1999; 319(7218): 1157-62.
13. Covacci A, Censini S, Bugnoli M, Petracca R, Burroni D, Macchia G, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci U S A 1993; 90(12): 5791-5.
14. Zhu J, Katz RJ, Quyyumi AA, Canos DA, Rott D, Csako G, et al. Association of serum antibodies to heat-shock protein 65 with coronary calcification levels: suggestion of pathogen-triggered autoimmunity in early atherosclerosis. Circulation 2004; 109(1): 36-41.
15. Niccoli G, Franceschi F, Cosentino N, Giupponi B, De MG, Merra G, et al. Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 2010; 21(4): 217-21.
16. Zhang S, Guo Y, Ma Y, Teng Y. Cytotoxin-associated gene-A-seropositive virulent strains of Helicobacter pylori and atherosclerotic diseases: a systematic review. Chin Med J (Engl) 2008; 121(10): 946-51.
17. Bush CA, VanFossen DB, Kolibash AJ, Magorien RD, Bacon JP, Ansel GM, et al. Cardiac catheterization and coronary angiography using 5 French preformed (Judkins) catheters from the percutaneous right brachial approach: a comparative analysis with the femoral approach. Cathet Cardiovasc Diagn 1993; 29(4): 267-72.
18. Berry C, L'Allier PL, Gregoire J, Lesperance J, Levesque S, Ibrahim R, et al. Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression. Circulation 2007; 115(14): 1851-7.
19. Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, et al. Helicobacter pylori infection is associated with decreased serum levels of high density lipoprotein, but not with the severity of coronary atherosclerosis. Lipids Health Dis 2009; 8: 59.
20. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di SG. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am Heart J 2006; 151(6): 1215-22.
21. Byrne MF, Murphy JF, Corcoran PA, Atherton JC, Sheehan KM, Cox D, et al. Helicobacter pylori induces cyclooxygenase-1 and cyclooxygenase-2 expression in vascular endothelial cells. Scand J Gastroenterol 2003; 38(10): 1023-30.
22. de Boer OJ, van der Wal AC, Becker AE. Atherosclerosis, inflammation, and infection. J Pathol 2000; 190(3): 237-43.
23. Franceschi F, Sepulveda AR, Gasbarrini A, Pola P, Silveri NG, Gasbarrini G, et al. Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 2002; 106(4): 430-4.
24. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, et al. Relationship of Helicobacter pylori infection to arterial stiffness in Japanese subjects. Hypertens Res 2005; 28(4): 283-92.